mTOR inhibitors sirolimus (rapamycin; Rapamune®) and everolimus (RAD001; Afinitor® [USA]; Votubia® [EU]) have been investigated in patients with TSC, most extensively as an alternative nonsurgical intervention for TSC-related SEGA. The gene discussed is MTOR; the disease is tuberous sclerosis.